Cryomass Technologies

Cryomass Technologies Net Margin

The Net Profit Margin of Cryomass Technologies (CRYM) as of Nov 19, 2026 is -95,600.12 %. In the previous year, Net Profit Margin was -1,512.04 % — a change of 6,222.59% (lower).

Net Margin

-95,600.12 %

YoY

6,222.59%

Last updated:

Net Profit Margin of Cryomass Technologies is 2023 -95,600.12 % . Net Profit Margin of Cryomass Technologies was 2022 -1,512.04 % . It decreases by 6,222.59% lower compared to the previous year.

Cryomass Technologies's net margin stands at -95,600.1%, down from -3.4% several years earlier.

The Cryomass Technologies Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2010
0.02 USD
Jan 1, 2011
-0.04 USD
Jan 1, 2012
-0.03 USD
Jan 1, 2013
-0.08 USD
Jan 1, 2019
-87.89 USD
Jan 1, 2020
-1,512.04 USD
Jan 1, 2023
-95,600.12 USD
The Cryomass Technologies Net Margin history
YEARNet MarginYoY
-95,600.12 %+6,222.59%
-1,512.04 %+1,620.37%
-87.89 %+110,390.45%
-0.08 %+135.98%
-0.03 %-18.26%
-0.04 %-308.25%
0.02 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cryomass Technologies Stock analysis

What does Cryomass Technologies do? CryoMass Technologies, Inc. operates medical marijuana dispensaries and related businesses, leveraging patented technology that utilizes liquid nitrogen to separate, collect, and protect high-value compounds from harvested plants. The firm owns a Trichome Separation unit, known as the CryoMass patented liquid nitrogen system, which is optimized for capturing fully intact cannabis and hemp trichomes along with terpenes. This system stabilizes and collects trichomes at harvest, preventing wasteful loss and functioning effectively within minutes after plants are cut or on fresh frozen and dried plant parts including trim. The company generates revenue by selling its proprietary Trichome Separation system to entities involved in the cultivation and processing of cannabis and hemp. By offering a solution that efficiently captures valuable compounds from various plant states, CryoMass Technologies targets customers seeking to maximize yield and quality in the medical marijuana sector. The business model relies on the unique capabilities of its liquid nitrogen technology to provide a superior alternative to traditional extraction methods, appealing to dispensaries and related businesses looking to enhance their operational efficiency and product integrity. Cryomass Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cryomass Technologies stock

Net Profit Margin of Cryomass Technologies is -95,600.12 % in 2023.

Net Profit Margin of Cryomass Technologies changed from -1,512.04 % to -95,600.12 %, representing a 6,222.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Cryomass Technologies since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Cryomass Technologies with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Cryomass Technologies

All Key Metrics — Cryomass Technologies